Apolipoprotein A-IV binds αIIbβ3 integrin and inhibits thrombosis - Xu, Xiaohong Ruby; Wang, Yiming; Adili, Reheman; Ju, Lining; Spring, Christopher M.; Jin, Joseph Wuxun; Yang, Hong; Neves, Miguel A. D.; Chen, Pingguo; Yang, Yan; Lei, Xi; Chen, Yunfeng; et al. (Nature communications, 2018)
Keywords: 13/31; 38/70; 631/443/592/1339; 631/443/592/75/593/567; 64/110; 64/60; 82/29; 82/58; 82/80; 82/83; 9/10; 96/63; Adult; Agglomeration; Animals; Apolipoprotein A; Apolipoproteins; Apolipoproteins A - genetics; Apolipoproteins A - metabolism; Apolipoproteins A - pharmacology; Aspartic Acid - metabolism; Beads; Binding; Binding Sites; Blood plasma; C-Terminus; Cardiovascular diseases; Cerebral infarction; Circadian Rhythm - physiology; Circadian rhythms; Disease Models, Animal; Health risk assessment; Heart diseases; Hemostasis; Hemostatics; Humanities and Social Sciences; Humans; Hyperactivity; Ligands; Lipid metabolism; Metabolism; Mice, Inbred C57BL; Mice, Transgenic; Molecular interactions; multidisciplinary; Myocardial infarction; N-Terminus; Plasma levels; Platelet aggregation; Platelet Aggregation - drug effects; Platelet Aggregation Inhibitors - pharmacology; Platelet Glycoprotein GPIIb-IIIa Complex - metabolism; Platelets; Postprandial Period; Recombinant Proteins - genetics; Recombinant Proteins - metabolism; Recombinant Proteins - pharmacology; Science; Science (multidisciplinary); Thromboembolism; Thrombosis; Thrombosis - drug therapy; Thrombosis - metabolism